Department of Diagnostic Sciences

Medicine & Life Sciences

1. Shear Strength 100%
2. Adhesives 85%
3. Fatigue 82%
4. Dentin 81%
5. phosphoric acid 68%
6. Jaw 49%
7. Mouth Mucosa 44%
8. Mouth 41%
9. Periodontal Cyst 40%
10. Dental Offices 35%
11. Odontogenic Cysts 34%
12. pembrolizumab 34%
13. Adenosquamous Carcinoma 34%
14. Denosumab 34%
15. Merkel Cell Carcinoma 33%
16. Bone Cysts 33%
17. Flexural Strength 31%
18. Protemp 30%
19. Health Occupations 30%
20. Hemangiosarcoma 30%
21. Dental Enamel 30%
22. Gout 29%
23. Germinal Center 28%
24. African Americans 28%
25. Osteonecrosis 28%
26. Temporomandibular Joint 27%
27. Lymphoma, Large B-Cell, Diffuse 27%
28. Optibond 27%
29. Neoplasms 26%
30. G-C Unifast LC 25%
31. Scotchbond 25%
32. Lip 24%
33. Mandible 23%
34. Tongue 22%
35. G-Bond 21%
36. Epithelium 21%
37. Health Personnel 21%
38. X-Rays 18%
39. B-Lymphocytes 18%
40. Radiation 18%
41. Neck 18%
42. Methylmethacrylate 18%
43. Head 17%
44. Students 17%
45. Squamous Cell Carcinoma 16%
46. Water 16%
47. Merkel Cells 16%
48. Technology 15%
49. Education 15%
50. Composite Resins 14%
51. Blood Vessels 14%
52. Skin 14%
53. Elastic Modulus 14%
54. Bone Density Conservation Agents 13%
55. Keratins 12%
56. Orthodontics 12%
57. Fibrin 12%
58. Scalp 12%
59. Stainless Steel 11%
60. Elderly 11%
61. Connective Tissue 11%
62. Analysis of Variance 11%
63. Ulcer 10%
64. Z100 composite resin 10%
65. Patient Selection 10%
66. Tooth 10%
67. Edema 9%
68. Differential Diagnosis 9%
69. Fibrosis 9%
70. Neuroendocrine Cells 8%
71. Programmed Cell Death 1 Receptor 8%
72. B-Cell Lymphoma 8%
73. luxatemp 8%
74. Uric Acid 8%
75. Consent Forms 8%
76. Direct Fluorescent Antibody Technique 7%
77. Adenocarcinoma 7%
78. Recurrence 7%
79. Asian Americans 7%
80. Therapeutics 7%
81. Inflammation 7%
82. Melanins 7%
83. Pigmentation 6%
84. Melanocytes 6%
85. Nerve Fibers 6%
86. Literature 6%
87. Maxilla 6%
88. Prime & Bond 6%
89. Urinary Bladder Neoplasms 5%
90. Infections 5%
91. Glandular and Epithelial Neoplasms 5%
92. Pharmaceutical Preparations 5%
93. European Continental Ancestry Group 5%
94. Control Groups 5%
95. villin 5%
96. Immunotherapy 5%
97. Diphosphonates 5%
98. Cysts 5%
99. Chemoradiotherapy 5%